Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00469209
What this trial is testing

Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00417911
What this trial is testing

Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 400
Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Testing effectiveness (Phase 2)Study completedNCT01237951
What this trial is testing

High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT01279694
What this trial is testing

Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)

Who this might be right for
Myeloma
Nantes University Hospital 72
Large-scale testing (Phase 3)Study completedNCT00443235
What this trial is testing

GEM05 for Patients With Multiple Myeloma More Than 65 Years Old

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 260
Testing effectiveness (Phase 2)UnknownNCT00508209
What this trial is testing

Bortezomib and High-dose Melphalan at Myeloma Relapse

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 50
Testing effectiveness (Phase 2)Looking for participantsNCT06028828
What this trial is testing

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationAllogeneic Stem Cell TransplantationHematologic Malignancies
University of California, Irvine 60
Early research (Phase 1)Study completedNCT01752257
What this trial is testing

EF5 in Melanoma Patients

Who this might be right for
Melanoma
Douglas Tyler 15
Large-scale testing (Phase 3)Study completedNCT01078454
What this trial is testing

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
National Cancer Institute (NCI) 11
Early research (Phase 1)Study completedNCT00089453
What this trial is testing

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Early research (Phase 1)Ended earlyNCT02043860
What this trial is testing

Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Illinois at Chicago 3
Not applicableNot Yet RecruitingNCT07644481
What this trial is testing

Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
AML (Acute Myelogenous Leukemia)Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Institute of Hematology & Blood Diseases Hospital, China 30
Large-scale testing (Phase 3)Study completedNCT01818752
What this trial is testing

Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 955
Not applicableLooking for participantsNCT06548958
What this trial is testing

A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases

Who this might be right for
Malignant Hematological Diseases
The First Affiliated Hospital of Soochow University 40
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)UnknownNCT01178645
What this trial is testing

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Seoul National University Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT00583622
What this trial is testing

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 13
Large-scale testing (Phase 3)Study completedNCT01413178
What this trial is testing

Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 205
Testing effectiveness (Phase 2)Study completedNCT00577278
What this trial is testing

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
City of Hope Medical Center 41
Next Page